M. Hohenegger - Concepedia

Author

M. Hohenegger

Also Known As

M HOHENEGGER, M Hohenegger, M. HOHENEGGER, M. Hohenegger, M.-A. Hohenegger, MARTIN HOHENEGGER, Martin HOHENEGGER, Martin Hohenegger

211

Publications

Citations

H-Index

Concepts

All Affiliations

University of Vienna Medical University of Vienna Vienna General Hospital Universität Hamburg University of Bath

About

M. Hohenegger is an author at University of Vienna specializing in medicine, physiology, and cellular physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	23	1.2K
2	Natural Sciences	7	7	224
3	Health Sciences	4	4	199
4	Public Health	1	1	10
5	Applied Physiology	1	1	32

M. Hohenegger

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose Andreas H. Guse, Cristina P. da Silva, Ingeborg Berg, Nature Second MessengerSignal TransductionMolecular PhysiologyT-regulatory CellPhysiology	1999	313
Phosphorylation of serine 2843 in ryanodine receptor-calcium release channel of skeletal muscle by cAMP-, cGMP- and CaM-dependent protein kinase J. Suko, Ingrid Maurer-Fogy, Brigitte Plank, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research Neuromuscular JunctionMuscle FunctionSignal TransductionMolecular PhysiologyBiochemistry	1993	172
Suramin analogues as subtype-selective G protein inhibitors. Michael Freissmuth, Stefan Boehm, W. Beindl, Molecular Pharmacology	1996	147
G <sub>sα</sub> -selective G protein antagonists M. Hohenegger, Maria Waldhoer, W. Beindl, Proceedings of the National Academy of Sciences	1998	136
Nicotinic acid–adenine dinucleotide phosphate activates the skeletal muscle ryanodine receptor M. Hohenegger, J. Suko, Regina Gscheidlinger, Biochemical Journal Muscle FunctionNeurotransmitterNeurotransmissionCellular PhysiologyMolecular Pharmacology	2002	130
Inhibition of receptor/G protein coupling by suramin analogues. W. Beindl, T Mitterauer, M. Hohenegger, Molecular Pharmacology	1996	124
Species difference in the G protein selectivity of the human and bovine A1-adenosine receptor. Ralf Jockers, Maurine E. Linder, M. Hohenegger, Journal of Biological Chemistry	1994	117
NAADP-mediated Ca <sup>2+</sup> signaling via type 1 ryanodine receptor in T cells revealed by a synthetic NAADP antagonist Werner Dammermann, Bo Zhang, Merle Nebel, Proceedings of the National Academy of Sciences ImmunologyT CellsCellular PhysiologyMolecular PharmacologyType 1	2009	105
Delineation of Myotoxicity Induced by 3-Hydroxy-3-methylglutaryl CoA Reductase Inhibitors in Human Skeletal Muscle Cells Julia Sacher, Lukas Weigl, Martin Werner, Journal of Pharmacology and Experimental Therapeutics	2005	105
Phosphorylation of the purified cardiac ryanodine receptor by exogenous and endogenous protein kinases M. Hohenegger, J. Suko Biochemical Journal Cardiac MuscleCellular PhysiologyCardiologyCell SignalingCardiomyopathy	1993	78

Page 1